Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog

Molecular and Cellular Biology

Volumn 19, Issue 2, 1999, Pages 1049-1055

  Takeyama, Ken Ichi ^a   Masuhiro, Yoshikazu ^a   Fuse, Hiroaki ^a   Endoh, Hideki ^a   Murayama, Akiko ^a   Kitanaka, Sachiko ^a   Suzawa, Miyuki ^a   Yanagisawa, Junn ^a   Kato, Shigeaki ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; GENE ACTIVATION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING;

ANIMALIA;

EID: 0032930547     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.2.1049     Document Type: Article

References (53)

1. Abe, J., Y. Moriya, M. Saito, Y. Sugawara, T. Suda, and Y. Nishii. 1986. Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha, 25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3. Cancer Res. 53:2534-2537.
2. Abe, J., T. Nakano, Y. Nishii, T. Matsumoto, E. Ogata, and K. Ikeda. 1991. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129:832-837.
3. Anzick, S. L., J. Kononen, R. L. Walker, D. O. Azorsa, M. M. Tanner, X. Y. Guan, G. Sauter, O. P. Kallioniemi, J. M. Trent, and P. S. Meltzer. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
4. Beato, M., P. Herrlich, and G. Schutz. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
5. Bikle, D. D., and S. Pillai. 1993. Vitamin D, calcium, and epidermal differentiation. Endocr. Rev. 14:3-19.
6. Bouillon, R., W. H. Okamura, and A. W. Norman. 1995. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev. 16:200-257.
7. Brzozowski, A. M., A. C. W. Pike, Z. Dauter, R. E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G. L. Greene, J. A. Gustafsson, and M. Carlquist. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758.
8. Cavailles, V., S. Dauvois, F. L'Horset, G. Lopez, S. Hoare, P. J. Kushner, and M. G. Parker. 1995. Nuclear factor RIP140 modulates transcriptional activation hy the estrogen receptor. EMBO J. 14:3741-3751.
9. Chakravarti, D., V. J. LaMorte, M. C. Nelson, T. Nakajima, I. G. Schulman, H. Juguilon, M. Montminy, and R. M. Evans. 1996. Role of CBP/P300 in nuclear receptor signalling. Nature 383:99-103.
10. Chakravarti, D., V. J. LaMorte, M. C. Nelson, T. Nakajima, I. G. Schulman, H. Juguilon, M. Montiminy, and R. M. Evans. 1996. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptor. Proc. Natl. Acad. Sci. USA 93:4948-4952.
11. Chen, H., R. J. Lin, R. L. Schiltz, D. Chakravarti, A. Nash, L. Nagy, M. L. Privalsky, Y. Nakatani, and R. M. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histidine acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580.
12. Darwish, H., and H. F. DeLuca. 1993. Vitamin D-regulated gene expression. Crit. Rev. Eukaryot. Gene Expr. 3:89-116.
13. Durand, B., M. Saunders, C. Gaudon, B. Roy, R. Lossun, and P. Chambon. 1994, Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:5370-5382.
14. Ebihara, K., Y. Masuhiro, T. Kitamoto, M. Suzawa, Y. Uematsu, T. Yoshizawa, T. Ono, H. Harada, K. Matsuda, T. Hasegawa, S. Masushige, and S. Kato. 1996. Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathway. Mol. Cell. Biol. 16:3393-3400.
15. Estojak, J., R. Brent, and E. A. Golemis. 1995. Correlation of two-hybrid affinity data with in vitro measurements. Mol. Cell. Biol. 15:5820-5829.
16. Feng, W., R. C. J. Ribeiro, R. L. Wagner, H. Nguyen, J. W. Apriletti, R. J. Fletterick, J. D. Baxter, P. J. Kushner, and B. L. West 1998 Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280:1747-1749.
17. Gill, R. K., L. M. Atkins, B. W. Hollis, and N. H. Bell. 1998. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1. Mol. Endocrinol. 12:57-65.
18. Halachmi, S., E. Marden, G. Martin, H. MacKay, C. Abbondanza, and M. Brown. 1994. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264:1455-1458.
19. Hansen, S. K., S. Takada, K. H. Jacobson, J. T. Lis, and R. Tjian. 1997. Transcription properties of a cell type-specific TATA-binding protein. TRF. Cell 91:71-83.
20. Hansen, S. K., and R. Tjian. 1995. TAFs and TFIIA mediate differential utilization of the tandem Adh promoters. Cell 82:565-575.
21. Haussler, M. R., D. J. Mangelsdorf, B. S. Kamm, C. M. Terpening, K. Yamaoka, E. A. Allegretto, A. R. Baker, J. Shine, D. P. McDonnell, M. Hughes, et al. 1988. Molecular biology of the vitamin D hormone. Recent Prog. Horm. Res. 44:263-305.
22. Haussler, M. R., G. K. Whitfield, C. A. Haussler, J. C. Hsieh, P. D. Thompson, S. H. Selznick, C. E. Dominguez, and P. W. Jurutka. 1998. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13:325-349.
23. Keery, D. M., E. Kalkhoven, S. Hoare, and M. G. Parker. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-735.
24. Henry, H. L., and A. W. Norman. 1978. Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability. Science 201: 835-837.
25. Ikeda, T., H. Kohno, T. Yamamuro, R. Kasai, S. Ohta, H. Okumura, J. Konishi, H. Kikuchi, and C. Shigeno. 1992. The effect of active vitamin D3 analogs and dexamethasone on the expression of osteocalcin gene in rat tibiae in vivo. Biochem. Biophys. Res. Commun. 189:1231-1235.
26. Imai, T., K. Matsuda, T. Shimojima, T. Hashimoto, Y. Masuhiro, T. Kitamoto, A. Sugita, K. Suzuki, H. Matsumoto, S. Masushige, V. Nogi, M. Muramatsu, H. Handa, and S. Kato. 1997. ERC-55, a binding protein for the papilloma virus E5 oncoprotein, specifically interacts with vitamin D receptor among nuclear receptors Biochem. Biophys. Res. Commun. 233:765-769.
27. Jurutka, P. W., J. C. Hsieh, L. S. Remus, G. K. Whitefleld, P. D. Thompson, C. A. Haussler, J. C. Blanco, K. Ozato, and M. R. Haussler. 1997. Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro. J. Biol. Chem. 272:14592-14599.
28. Kalkhoven, E., J. E. Valentine, D. M. Keen, and M. G. Parker. 1998. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J. 17:232-243.
29. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
30. Kato, S., H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, and P. Chambon. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494.
31. Kato, S., H. Sasaki, M. Suzawa, S. Masushige, L. Tora, P. Chambon, and H. Gronemeyer. 1995. Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors. Mol. Cell. Biol. 15:5858-5867.
32. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. The nuclear receptor superfamily. Cell 83:835-839.
33. Masuyama, H., C. M. Brownfield, R. St-Arnaud, and P. N. MacDonald. 1997. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol. Endocrinol. 11:1507-1517.
34. May, M., G. Mengus, A. C. Lavigne, P. Chambon, and I. Davidson. 1996. Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J. 15:3093-3104.
35. Murayama, E., K. Miyamoto, N. Kubodera, T. Mori, and I. Matsunaga. 1986. Synthetic studies of vitamin D3 analogues. Synthesis of 22-oxavitamin D3 analogues. Chem. Pharm. Bull. (Tokyo) 34:4410-4413.
36. Ogryzko, V. V., R. L. Schlitz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
37. Okano, T., N. Tsugawa, S. Masuda, A. Takeuchi, T. Kobayashi, Y. Takita, and Y. Nishii. 1989. Regulatory activities of 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism. Biochem. Biophys. Res. Commun. 163:1444-1449.
38. Onate, S. A., S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
39. Rachez, C., Z. Suldan, J. Ward, C. P. Chang, D. Burakov, B. H. Erdjument, P. Tempst, and L. P. Freedman. 1998. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev. 12:1787-1800.
40. Sasaki, H., H. Harada, Y. Handa, H. Morino, M. Suzawa, E. Shimpo, T. Katsumata, Y. Masuhiro, K. Matsuda, K. Ebihara, T. Ono, S. Masushige, and S. Kato. 1995. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Biochemistry 34:370-377.
41. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schafhausen, and L. C. Cantley. 1993. SH3 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
42. Spencer, T. E., G. Jenster, M. M. Burcin, C. D. Allis, J. Zhou, C. A. Mizzen, N. J. McKenna, S. A. Onate, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-198.
43. Takeyama, K., S. Kitanaka, T. Sato, M. Kobori, J. Yanagisawa, and S. Kato. 1997. 25-Hydroxyvitamin D3 1 alpha-hydroxylase and vitamin D synthesis. Science 277:1827-1830.
44. Tanaka, Y., H. F. DeLuca, Y. Kobayashi, and N. Ikekawa. 1984. 26,26,26,27, 27,27-Hexafluoro-1,25-dihydroxyvitamin D3: a highly potent, long-lasting analog of 1,25-dihydroxyvitamin D3. Arch. Biochem. Biophys. 229:348-354.
45. Tanaka, Y., D. N. Pahuja, J. K. Wichmann, L. H. DeLuca, Y. Kobayashi, T. Taguchi, and N. Ikekawa. 1982. 25-Hydroxy-26,26,26,27,27,27-hexafluorovitamin D3: biological activity in the rat. Arch. Biochem. Biophys. 218:134-141.
46. Tansey, W. P., and W. Herr. 1997. TAFs: guilt by association: Cell 88:729-732.
47. Voegel, J. J., M. J. Heine, M. Tini, V. Vilat, P. Chambon, and H. Gronemeyer. 1998. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17:507-519.
48. Voegel, J. J., M. J. Heine, C. Zechel, P. Chambon, and H. Gronemeyer. 1996. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:3667-3675.
49. vom, B. E., C. Zechel, D. Heery, M. J. Heine, J. M. Garnier, V. Vivat, D. B. Le, H. Gronemeyer, P. Chambon, and R. Losson. 1996. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15:110-124.
50. Wurtz, J. M., W. Bourguel, J. P. Renaud, V. Vivat, P. Chambon, D. Moras, and H. Gronemeyer. 1996. A canonical strucuture for the ligand-binding domain of nuclear receptors. Natl. Struct. Biol. 3:87-94.
51. Xu, J., Y. Qiu, F. J. DeMayo, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1998. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279:1922-1925.
52. Yen, S., and C. Chang. 1996. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA 93:5517-5521.
53. Yoshizawa, T., Y. Handa, Y. Uematsu, S. Takeda, K. Sekine, Y. Yoshihara, T. Kawakami, K. Arioka, H. Sato, Y. Uchiyama, S. Masushige, A. Fukamizu, T. Matsumoto, and S. Kato. 1997. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16:391-396.